drugset / Trial / NCT04885049

Comparing the Efficacy of Anti-secretory Versus Oral Immunoglobulins for Reducing the Episodes of Diarrhea in Children

NCT04885049 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Children 1-12 years presenting/admitted with acute diarrhea will be enrolled in the study after taking informed consent from the parents. Patients will be randomly allocated to two equal groups. Group A (GA) will receive anti secretory 1.5mg/kg/dose, three doses in 24 hours along with oral rehydration, while Group B (GB) will receive a single dose of bovine immunoglobulins. Response to treatment will be assessed by recording the frequency of loose stools after 72 hrs. Data will be collected through a structured proforma.

Timeline

Start
2021-09-01
Primary completion
2022-02-01
Completion
2022-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject DiaResQ Children's Powder for Suspension Protein / enzyme biologic 7 g Oral
Subject Racecadotril Small molecule 1.5 mg/kg Oral

Indications